Effect of short‐interval rituximab and high‐dose corticosteroids on kidney function in systemic sclerosis: Long‐term experience of a single centre

INTRODUCTION: Scleroderma renal crisis (SRC) is a rare but one of the most recognised complications of systemic sclerosis (SSc). Corticosteroid (CS) use has been considered as a major risk factor for SRC. Several studies reported the efficacy of rituximab (RTX) with an acceptable safety profile in S...

Descripción completa

Detalles Bibliográficos
Autores principales: Odler, Balazs, Hebesberger, Carina, Hoeflechner, Lukas, Pregartner, Gudrun, Gressenberger, Paul, Jud, Philipp, Zenz, Sabine, Eller, Kathrin, Rosenkranz, Alexander R., Moazedi‐Fuerst, Florentine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Short Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8243981/
https://www.ncbi.nlm.nih.gov/pubmed/33540483
http://dx.doi.org/10.1111/ijcp.14069

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8243981/
https://www.ncbi.nlm.nih.gov/pubmed/33540483
http://dx.doi.org/10.1111/ijcp.14069

Ejemplares similares